Biotech SEO demands regulatory compliance, evidence-based content, and patient journey mapping. In 2026 that also means showing up accurately when patients ask ChatGPT, Perplexity, and Google's AI Overviews about their condition – we build SEO and GEO strategies that scale patient acquisition while meeting FDA guidelines.
The Problem
Generic SEO agencies create compliance risk on Google and now on AI answer engines
Most SEO agencies have never navigated FDA guidelines, HIPAA, or clinical trial regulations, and even fewer understand how AI Overviews and chatbot answer engines pull from indexed pages to summarize treatment options. They write patient-facing content that creates legal liability, use testimonials that violate medical advertising rules, and optimize for keywords that attract the wrong patient populations. When that content gets scraped into an AI-generated answer, the liability compounds because the company can't control how the claim gets paraphrased. The result: compliance violations, wasted ad spend, and inaccurate claims circulating outside the company's own site.
Medical SEO requires an evidence hierarchy that traditional marketers don't understand
Biotech content must follow evidence hierarchies built from peer-reviewed research, not marketing hunches. Traditional SEO relies on keyword volume and competitor gap analysis. Medical SEO requires understanding clinical endpoints, patient-reported outcomes, and regulatory pathways well enough to write about them accurately. Companies end up ranking for irrelevant searches while missing the specific patient population that needs their therapeutic approach.
Patient acquisition costs spiral when SEO doesn't align with clinical trial recruitment
Biotech companies burn through Series B funding on broad awareness campaigns while struggling to fill clinical trials. SEO strategy has to integrate patient recruitment pipelines, geographic trial site distribution, and inclusion-criteria targeting, or the traffic never converts. Paid search costs for competitive therapeutic areas keep climbing in 2026, making organic and AI-answer visibility a larger share of a realistic budget, not a nice-to-have.
How We Help
Our biotech SEO practice starts with regulatory compliance mapping. We audit your current content against FDA promotional guidelines, medical device regulations, and clinical claims requirements. This foundation prevents costly violations while identifying content gaps that actually impact patient discovery.
Next, we map patient journey flows from symptom awareness through treatment decision-making. Biotech patients research differently than B2B buyers – they validate information across multiple medical sources, seek peer support communities, and need extensive education before engaging with a trial opportunity. Our keyword research and content optimization target this multi-stage validation process: condition-specific searches, treatment comparison queries, and clinical trial eligibility questions that drive qualified patient interest, not just high-volume medical terms.
We also structure content for generative engine optimization, GEO – the practice of getting cited accurately when patients ask ChatGPT, Perplexity, or Google's AI Overviews about their condition. That means clear entity definitions, source citations to peer-reviewed evidence, and structured data that helps answer engines quote your content correctly instead of summarizing a competitor's page or an outdated forum post. GEO doesn't replace traditional SEO in life sciences – it depends on the same regulatory-compliant, evidence-based foundation.
Our execution model embeds directly with your medical affairs and regulatory teams. We build content calendars aligned with clinical milestones, regulatory submissions, and trial enrollment phases. Every piece goes through your medical review process before publication, so accuracy and SEO performance are decided together instead of traded off. This integrated growth strategy means your SEO and GEO investment actually supports clinical development timelines rather than working against them.
Our measurement approach uses attribution models built for a months-long research cycle: condition-specific search visibility, AI-answer citation tracking, patient education engagement, and conversion to trial inquiry forms or physician referral programs.
What we deliver
- Regulatory compliance SEO audit – review of current content against FDA, medical device, and clinical claims regulations
- Patient journey keyword mapping – condition-specific search targeting from symptom awareness through treatment decision
- Generative engine optimization audit – structuring evidence-based content so AI Overviews, ChatGPT, and Perplexity cite it accurately instead of a competitor's or an outdated source
- Clinical trial recruitment SEO – geographic and demographic targeting aligned with trial site distribution and inclusion criteria
- Physician referral program optimization – SEO targeting healthcare providers in your therapeutic areas
Most biotech companies still optimize for a single search box when the real battleground is every place a patient asks about their condition – Google, an AI Overview, or a chatbot. The content that wins in all three is the same content: evidence-based, source-cited, and written for a decision that takes months, not minutes.
Our Methodology
Our biotech SEO and GEO methodology follows a 90-day sprint aligned with clinical development phases. Weeks 1-2: regulatory compliance audit and patient journey mapping. Weeks 3-6: evidence-based keyword research, AI-answer citation gap analysis, and competitive landscape review within regulatory constraints. Weeks 7-12: content strategy development with medical affairs collaboration and regulatory pre-approval built into the workflow, publishing content structured for both classic search rankings and generative-engine citation. What makes this different from traditional medical marketing: we embed with your clinical teams to understand patient selection criteria, trial site geography, and enrollment timelines, so SEO effort tracks directly to trial fill rate and treatment uptake instead of vanity traffic.
How We Work
First 30 days: regulatory compliance audit, patient journey research, and clinical team integration. We review your current digital presence against FDA promotional guidelines and flag compliance gaps that could create legal exposure, including how existing content is already being surfaced in AI answers. Weeks 5-8: evidence-based content strategy development with medical affairs collaboration, with every piece routed through your existing regulatory review process rather than a parallel one we invent. Weeks 9-12: implementation with attribution tracking that follows patient progression from search or AI-answer discovery through clinical trial screening or treatment selection. Team structure includes a dedicated life sciences SEO strategist working directly with your medical affairs, regulatory, and clinical operations teams – you provide trial protocols, inclusion criteria, and regulatory guidelines; we handle content, technical optimization, and attribution. Monthly reporting covers condition-specific search visibility, AI-citation accuracy, and conversion to trial inquiries or physician referrals. Typical engagements run 6-9 months to align with clinical development timelines.
- Patient acquisition cost reduction
- Clinical trial enrollment acceleration
- Regulatory-compliant visibility across search and AI answers
- Physician referral pipeline growth
If your biotech & pharma company needs seo & geo leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
How much does SEO for biotech companies cost?
Biotech SEO and GEO engagements typically run $15K-$35K monthly depending on therapeutic area, regulatory complexity, and clinical trial timelines. That compares favorably to traditional medical advertising, which often runs $50K-$100K monthly with far less attribution. Because life sciences sales cycles run 12-18 months, SEO investment compounds instead of resetting with each campaign.
How long before we see results from biotech SEO?
Regulatory compliance fixes show up within 30 days. Organic visibility for condition-specific terms typically improves in 60-90 days, and citation in AI Overviews or chatbot answers tends to follow once the underlying content is authoritative and well-sourced. Patient inquiry volume and clinical trial referrals usually move in months 4-6 as content authority builds. The real milestone is syncing that momentum with trial enrollment and regulatory submission timelines.
Do you optimize for AI Overviews and chatbot answers, or just Google rankings?
Both, because they draw on the same underlying content. We structure evidence-based pages with clear entity definitions, source citations, and structured data so AI Overviews, ChatGPT, and Perplexity can extract and cite them accurately. We also audit how your condition and therapy are represented in AI answers today, since a misattributed claim in a chatbot response is a compliance risk you did not create but still own.
How does your SEO team work with our medical affairs and regulatory teams?
Our life sciences strategist attends your clinical development meetings and works inside your existing regulatory review process rather than building a parallel one. Every piece gets medical sign-off before it publishes, with SEO and GEO structure built in from the first draft instead of bolted on after. That prevents both compliance delays and last-minute rewrites that break search or AI-citation performance.
What makes Winston Francois different from a medical marketing agency?
Medical marketing agencies optimize for awareness and education. We optimize for patient acquisition and clinical trial support, and now for accurate representation in AI-generated answers. Our strategies tie directly to clinical development timelines, trial enrollment goals, and physician referral programs. We measure success by patient progression through your clinical funnel, not organic traffic volume alone.
How do you measure ROI from biotech SEO and GEO work?
We track condition-specific search visibility, citation accuracy in AI-generated answers, patient education engagement, and conversion to trial screening forms or physician referral outcomes. Attribution follows the patient journey from initial search or AI-answer discovery through clinical trial enrollment or treatment initiation. Reporting ties to clinical milestones and regulatory submission phases, not raw traffic.
What type of biotech company is the right fit for this service?
Series A-C biotechs with active clinical trials or approved therapies targeting a defined patient population. Companies spending $50K or more monthly on patient acquisition, or struggling to fill trial sites, benefit the most. The first step is a regulatory compliance and AI-visibility audit to find where SEO and GEO can actually move enrollment or prescription numbers.
